Demetri GD, von Mehren M, Antonescu CR et al (2010) NCCN task force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw 8(Suppl 2):S1–S41
Article CAS PubMed PubMed Central Google Scholar
Blay JY, Bonvalot S, Casali P et al (2005) GIST consensus meeting panelists. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol 16:566–578
Choi H, Charnsangavej C, Faria SC et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25:1753–1759
Sepe PS, Brugge WR (2009) A guide for the diagnosis and management of gastrointestinal stromal cell tumors. Nat Rev Gastroenterol Hepatol 6:363–371
Scarpa M, Bertin M, Ruffolo C et al (2008) A systematic review on the clinical diagnosis of gastrointestinal stromal tumors. J Surg Oncol 98:384–392
Hedenström P, Nilsson B, Demir A et al (2017) Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies. World J Gastroenterol 23:5925–5935
Article PubMed PubMed Central Google Scholar
Hedenström P, Marschall HU, Nilsson B et al (2018) High clinical impact and diagnostic accuracy of EUS- guided biopsy sampling of subepithelial lesions: a prospective, comparative study. Surg Endosc 32:1304–1313
Philipper M, Hollerbach S, Gabbert HE et al (2010) Prospective comparison of endoscopic ultrasound-guided fine-needle aspiration and surgical histology in upper gastrointestinal submucosal tumors. Endoscopy 42:300–305
Article CAS PubMed Google Scholar
Akahoshi K, Sumida Y, Matsui N et al (2007) Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration. World J Gastroenterol 13:2077–2082
Article PubMed PubMed Central Google Scholar
Okasha HH, Naguib M, El Nady M et al (2017) Role of endoscopic ultrasound and endoscopic-ultrasound- guided fine-needle aspiration in endoscopic biopsy negative gastrointestinal lesions. Endosc Ultrasound 6:156–161
Article PubMed PubMed Central Google Scholar
Bean SM, Baker A, Eloubeidi M et al (2011) Endoscopic ultrasound-guided fine-needle aspiration of intrathoracic and intra-abdominal spindle cell and mesenchymal lesions. Cancer Cytopathol 119:37–48
Sepe PS, Moparty B, Pitman MB et al (2009) EUS-guided FNA for the diagnosis of GI stromal cell tumors: sensitivity and cytologic yield. Gastrointest Endosc 70:254–261
Hoda KM, Rodriguez SA, Faigel DO (2009) EUS-guided sampling of suspected GI stromal tumors. Gastrointest Endosc 69:1218–1223
Chatzipantelis P, Salla C, Karoumpalis I et al (2008) Endoscopic ultrasound-guided fine needle aspiration biopsy in the diagnosis of gastrointestinal stromal tumors of the stomach. A study of 17 cases. J Gastrointestin Liver Dis 17:15–20
Okubo K, Yamao K, Nakamura T et al (2004) Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach. J Gastroenterol 39:747–753
Vander Noot MR III, Eloubeidi MA, Chen VK et al (2004) Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 102:157–163
Ando N, Goto H, Niwa Y et al (2002) The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 55:37–43
Gu M, Ghafari S, Nguyen PT et al (2001) Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol 25:343–250
Article CAS PubMed Google Scholar
Hedenstrom P, Nilsson B, Andersson C et al (2016) A personalized treatment of gastrointestinal stromal tumors is enabled by analyzing endoscopic ultrasound‒guided biopsies: a prospective, ten-year cohort study. United European Gastroenterology Journal. Conference: 24th United European Gastroenterology Week, UEG. Austria 4 (5 Supplement 1):A 599
Joensuu H, Reichardt P, Eriksson M et al (2014) Gastrointestinal stromal tumor: a method for optimizing the timing of CT scans in the follow-up of cancer patients. Radiology 271:96–103
Cai PQ, Lv XF, Tian L et al (2015) CT characterization of duodenal gastrointestinal stromal tumors. Am J Roentgenol 204:988–993
Plumb AA, Kochhar R, Leahy M et al (2013) Patterns of recurrence of gastrointestinal stromal tumour (GIST) following complete resection: implications for follow-up. Clin Radiol 68:770–775
Article CAS PubMed Google Scholar
Ghanem N, Altehoefer C, Furtwängler A et al (2003) Computed tomography in gastrointestinal stromal tumors. Eur Radiol 13:1669–1678
Samiian L, Weaver M, Velanovich V (2004) Evaluation of gastrointestinal stromal tumors for recurrence rates and patterns of long-term follow-up. Am Surg 70:187–191
Yu MH, Lee JM, Baek JH et al (2014) MRI features of gastrointestinal stromal tumors. Am J Roentgenol 203:980–991
Tateishi U, Hasegawa T, Satake M et al (2003) Gastrointestinal stromal tumor. Correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr 27:792–798
Gayed I, Vu T, Iyer R et al (2004) The role of 18 F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med 45:17–21
Kaneta T, Takahashi S, Fukuda H et al (2009) Clinical significance of performing 18 F-FDG PET on patients with gastrointestinal stromal tumors: a summary of a Japanese multicenter study. Ann Nucl Med 23:459–464
Kim SJ, Lee SW (2018) Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: a systematic review and meta-analysis. J Gastroenterol Hepatol 33:576–582
Goerres GW, Stupp R, Barghouth G et al (2005) The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 32:153–162
Article CAS PubMed Google Scholar
Winant AJ, Gollub MJ, Shia J et al (2014) Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors. AJR Am J Roentgenol 203:306–314
Article PubMed PubMed Central Google Scholar
Schmidt S, Dunet V, Koehli M et al (2013) Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18 F-FDG PET/CT. Acta Radiol 54:837–842
Koch MR, Jagannathan JP, Shinagare AB et al (2013) Imaging features of primary anorectal gastrointestinal stromal tumors with clinical and pathologic correlation. Cancer Imaging 12:557–565
Article CAS PubMed PubMed Central Google Scholar
Young H, Baum R, Cremerius U et al (1999) Measurement of clinical and subclinical tumor response using [18 F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35:1173–1182
Wahl RL, Jacene H, Kasamon Y et al (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50(Suppl 1):122S-150S
Article CAS PubMed Google Scholar
Chacón M, Eleta M, Espindola AR et al (2015) Assessment of early response to imatinib 800 mg after 400 mg progression by 18F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors. Future Oncol 11:953–964
Goldstein D, Tan BS, Rossleigh M et al (2005) Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response - an AGITG study. Oncology 69:326–332
Stroobants S, Goeminne J, Seegers M et al (2003) 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 39:2012–2020
Article CAS PubMed Google Scholar
Yokoyama K, Tsuchiya J, Nakamoto Y et al (2021) Additional value of [18F] FDG PET or PET/CT for response assessment of patients with gastrointestinal stromal tumor undergoing molecular targeted therapy: a meta-analysis. Diagnostics (Basel) 11:475
Article CAS PubMed Google Scholar
Hirota S (2018) Differential diagnosis of gastrointestinal stromal tumor by histopathology and immunohistochemistry. Transl Gastroenterol Hepatol 3:27
Comments (0)